Paxlovid will be used on elderly patients, and those with chronic kidney issues, cardiovascular or chronic lung disease, diabetes, and other high risk factors for Covid-19, the Chinese drugs regulator said. Photo: Reuters
China approves Pfizer’s Covid-19 pill Paxlovid for emergency use
- Oral pill to be given to adults with mild to moderate Covid-19 with co-morbidities, and high risk of progression to severe disease, drug regulator says
- Pfizer will be required to continue with research work and submit the results of follow-up studies for a general approval
Follow your favourite topic and get notified
Paxlovid will be used on elderly patients, and those with chronic kidney issues, cardiovascular or chronic lung disease, diabetes, and other high risk factors for Covid-19, the Chinese drugs regulator said. Photo: Reuters
